Skip to main content
  • Five Startups on Fast Track to Grow Their Businesses Courtesy of Baltimore’s Big Names in Fitness and Health Care

    M-1 Ventures’ accelerator program to provide emerging businesses funding and mentorship

    Read More
  • Gliknik Announces Dosing of First Patient in Phase 2 Trial

    Clinical Study Targeting Prevention of Recurrence of High-Risk Oral Cavity Cancer

  • Lentigen Technology Inc. Acquires UMB Start-Up, Living Pharma, Inc.

    Living Pharma is the first UMB New Ventures Initiative start-up to execute a successful exit.

    Read More
  • Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke

    Phase 3-ready program complements Biogen’s ongoing development efforts in stroke

    Read More
  • UMB’S New Ventures Initiative Fosters Commercialization

    Innovative science at the UMB is getting an extra boost through a program fueled by UM Ventures called the “New Ventures Initiative” (NVI) (headquartered in the Lion Brothers Building)

    Read More
  • Announcing the New Maryland Momentum Fund

    In an effort to increase commercialization of its leading-edge research and support the growth of promising companies, the University System of Maryland (USM) is launching a new $25M early-stage investment fund, the Maryland...

    Learn More
  • Hot Technologies Available for Licensing

    UM Ventures is organized to move research outcomes into products and services, tools and diagnostics that will benefit society.

    Learn More

Upcoming Events

Receive Tech Alerts

Sign up to receive the UM Ventures e-newsletter, new technology announcements, and other news.

Select Your Interest(s)
University of Maryland, College Park
University of Maryland, Baltimore

UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.

Learn More